All Stories

  1. Gestational diabetes mellitus care re‐imagined – A cost‐minimisation analysis: Cost savings from a tertiary hospital, using a novel, digital‐based gestational diabetes management model
  2. Artificial intelligence: Augmenting telehealth with large language models
  3. The roles and perspectives of an informatics pharmacist practicing in the Australian healthcare setting: a qualitative study
  4. Cost-effectiveness of telehealth-delivered nutrition interventions: a systematic review of randomized controlled trials
  5. Inter-rater reliability of the occupational violence risk assessment tool for emergency departments
  6. Assessing the Effect of an Inpatient Smoking Cessation Brief Intervention Tool on Long-Term Smoking Cessation Rates and Patient Interest for Nicotine Replacement Therapy: A Retrospective Analysis
  7. Medicare reimbursed telehealth exercise physiology services were underutilised through the coronavirus (COVID-19) pandemic: an ecological study
  8. An evaluation of telephone versus videoconference consults for pre-treatment medication history taking by cancer pharmacists
  9. Costs to the Medicare Benefits Schedule for general practitioner consultations: A time-series analysis
  10. Dementia ECHO: Evaluation of a telementoring programme to increase dementia knowledge and skills in First Nations-led health services
  11. Health literacy, dementia knowledge and perceived utility of digital health modalities among future health professionals
  12. Three-dimensional (3D) printing for post-traumatic orbital reconstruction, a systematic review and meta-analysis
  13. Exploring factors of uneven use of telehealth among outpatient pharmacy clinics during COVID-19: A multi-method study
  14. The impact of telehealth policy changes on general practitioner consultation activity in Australia: a time-series analysis
  15. Increase in telemental health services on the Medicare Benefits Schedule after the start of the coronavirus pandemic: data from 2019 to 2021
  16. Telehealth sustainability after COVID-19 – can you see me by video?
  17. How have temporary Medicare telehealth item numbers impacted the use of dietetics services in primary care settings?
  18. Are Telehealth-Delivered Nutrition Care Interventions Cost-Effective for Managing Chronic Diseases? A Systematic Review of All Payer Perspectives
  19. Economic Evaluations of Remote Patient Monitoring for Chronic Disease: A Systematic Review
  20. Implications of increased telehealth use on organisations providing mental health services during COVID-19
  21. Infusion reaction incidence after switching all patients to an infliximab biosimilar in an Australian hospital
  22. Validity and reliability of the novel three‐item occupational violence patient risk assessment tool
  23. Associations between mental illness and non-medical use of prescription opioids among a sample of people who use drugs in Australia and New Zealand
  24. Mental illnesses as a potential risk factor for non‐medical use of prescription opioids: a narrative review
  25. Is the use of ranitidine required as a pre‐medication to prevent hypersensitivity reactions to paclitaxel?
  26. The right time and place: the need for seven‐day pharmacist service models
  27. Changing from telephone to videoconference for pre-treatment pharmacist consults in cancer services: Impacts to funding and time efficiency
  28. Enhancing a community palliative care service with telehealth leads to efficiency gains and improves job satisfaction
  29. Optimising specialist geriatric medicine services by telehealth
  30. Specialist consultation activity and costs in Australia: Before and after the introduction of COVID-19 telehealth funding
  31. Economic evaluations of videoconference and telephone consultations in primary care: A systematic review
  32. Infliximab switching from reference product to biosimilar: a review of evidence regarding the clinical efficacy, safety profile and immunogenicity
  33. Text automation tool to improve pharmacist productivity and work capacity in a digital hospital: a pilot study
  34. Consumer Preference and Willingness to Pay for Direct-to-Consumer Mobile Teledermoscopy Services in Australia
  35. Factors influencing the effectiveness of remote patient monitoring interventions: a realist review
  36. An evaluation of pharmacist activity in hospital outpatient clinics
  37. Why telehealth does not always save money for the health system
  38. Does the Choice Between a Telehealth and an In-Person Appointment Change Patient Attendance?
  39. An overview of the effect of telehealth on mortality: A systematic review of meta-analyses
  40. The clinical effectiveness of telehealth: A systematic review of meta-analyses from 2010 to 2019
  41. Patient preferences for specialist outpatient video consultations: A discrete choice experiment
  42. Addressing concerns and adapting psychological techniques for videoconsultations: a practical guide
  43. What can we do about occupational violence in emergency departments? A survey of emergency staff
  44. Does remote patient monitoring reduce acute care use? A systematic review
  45. Exploring paramedics’ intention to use a specialist palliative care telehealth service
  46. Paying for Telemedicine After the Pandemic
  47. A Systematic Review and Meta-Analysis of Change in Health-Related Quality of Life for Interactive Telehealth Interventions for Patients With Asthma
  48. A retrospective review examining intravenous iron infusion dosing methods
  49. The pharmacist informatician: providing an innovative model of care during the COVID-19 crisis
  50. Skin Doctor Consultations Using Mobile Teledermoscopy: Exploring Virtual Care Business Models
  51. Determining if Telehealth Can Reduce Health System Costs: Scoping Review
  52. An audit of the quantity of immediate release oxycodone 5 mg tablets prescribed for discharge: an area for improved opioid stewardship?
  53. Building on the momentum: Sustaining telehealth beyond COVID-19
  54. Long-term effects of childhood speech and language disorders: A scoping review
  55. Evaluating the utility of a Smoking Cessation Clinical Pathway tool to promote nicotine prescribing and use among inpatients of a tertiary hospital in Brisbane, Australia
  56. Nicotine vaping products as a harm reduction tool among smokers: Review of evidence and implications for pharmacy practice
  57. Transit Care Hub pharmacist: improving patient flow within the hospital
  58. A Systematic Review of Pediatric Telediabetes Service Models
  59. Economic Advantages of Telehealth and Virtual Health Practitioners: Return on Investment Analysis
  60. Use of Reimbursed Psychology Videoconference Services in Australia: An Investigation Using Administrative Data
  61. Commentary on Conigrave et al . (2020): Meta‐analysis of drinking patterns in Aboriginal and Torres Strait Islander populations highlights policy and research opportunities
  62. Current Economic Evidence for Teledermoscopy
  63. The Role of Telehealth in Reducing the Mental Health Burden from COVID-19
  64. Telehealth for global emergencies: Implications for coronavirus disease 2019 (COVID-19)
  65. Integrating a pharmacist into the perioperative setting
  66. Is Teledermoscopy Ready to Replace Face-to-Face Examinations for the Early Detection of Skin Cancer? Consumer Views, Technology Acceptance, and Satisfaction with Care
  67. Accuracy checking of dispensed medications by a pharmacy technician: a hospital case study
  68. Telehealth uptake in general practice as a result of the coronavirus (COVID-19) pandemic
  69. The breakeven point for implementing telehealth
  70. A cost-consequence analysis comparing patient travel, outreach, and telehealth clinic models for a specialist diabetes service to Indigenous people in Queensland
  71. Immersive Virtual Reality in Health Care: Systematic Review of Technology and Disease States
  72. A meta-analysis of pharmacists and pharmacy technicians’ accuracy checking proficiency
  73. A Commentary on the Dose–Response Relationship of Alcohol and Injury: Effects of Country‐Level Drinking Patterns and Alcohol Policies
  74. Pharmacy-led ward-based education reduces pharmaceutical waste and saves money
  75. Direct-to-consumer mobile teledermoscopy for skin cancer screening: Preliminary results demonstrating willingness-to-pay in Australia
  76. What do Australian dermatologists expect to be paid for store-and-forward teledermoscopy? A preliminary investigation
  77. Cost-effectiveness of Skin Cancer Referral and Consultation Using Teledermoscopy in Australia
  78. Economic evaluation strategies in telehealth: Obtaining a more holistic valuation of telehealth interventions
  79. Inpatient smoking cessation - turn to your clinical pharmacist
  80. Knowledge and attitudes of final year pharmacy students toward opioid substitution therapy
  81. Economics of teledermatology